Die Therapie der Osteoporose aus dem Blickwinkel einer auf Evidenz basierenden Medizin

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Medizinische Klinik

• Publication date

  2001-05-15

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/PL00002204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Bisphosphonate in der Therapie der Osteoporose

  2001cited by this paper
• Prevention of hip fracture in elderly people with use of a hip protector.

  2000cited by this paper
• A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

  2000cited by this paper
• Risk Factors for Perimenopausal Fractures: A Prospective Study

  2000cited by this paper
• Parathyroid hormone 1–34 (hpth 1–34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis — results from a placebo‐controlled randomized trial

  2000cited by this paper
• The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial

  2000cited by this paper
• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

  2000cited by this paper
• Effects of a Short‐Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women

  2000cited by this paper
• Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial

  2000cited by this paper
• Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

  1999cited by this paper
• Bone Turnover and the Response to Alendronate Treatment in Postmenopausal Osteoporosis

  1999cited by this paper
• Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

  1999cited by this paper
• Alendronate and fracture prevention.

  1999cited by this paper
• Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden

  1999cited by this paper
• Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.

  1999cited by this paper
• EVIDENCE‐BASED MEDICINE AND OSTEOPOROSIS: A COMPARISON OF FRACTURE RISK REDUCTION DATA FROM OSTEOPOROSIS RANDOMISED CLINICAL TRIALS

  1999cited by this paper
• Die Kosten hüftgelenksnaher Frakturen in Deutschland: Eine prospektive Untersuchung

  1999cited by this paper
• Time since Vertebral Fracture: An Important Variable Concerning Quality of Life in Patients with Postmenopausal Osteoporosis

  1999cited by this paper
• Added value of bone mineral density in hip fracture risk scores.

  1999cited by this paper
• Vitamin D and Hip Fracture.

  1999cited by this paper
• Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomised clinical trials.

  1999cited by this paper
• Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.

  1999cited by this paper
• Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• BIOCHEMICAL MARKERS OF BONE TURNOVER

  1998cited by this paper
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

  1998cited by this paper
• EFFECTS OF RALOXIFENE ON BONE MINERAL DENSITY, SERUM CHOLESTEROL CONCENTRATIONS, AND UTERINE ENDOMETRIUM IN POSTMENOPAUSAL WOMEN

  1998cited by this paper
• The Effect of Sodium Monofluorophosphate plus Calcium on Vertebral Fracture Rate in Postmenopausal Women with Moderate Osteoporosis

  1998cited by this paper
• Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

  1998cited by this paper
• Die Epidemiologie der vertebralen Osteoporose in Europa: Prävalenz, Risikofaktoren und Krankheitslast in Deutschland (EVOS)

  1998cited by this paper
• Osteoporose-Therapie Ein pluralistischer Ansatz

  1998cited by this paper
• Evidence-based management of patients with osteoporosis.

  1998cited by this paper
• Treatment of postmenopausal osteoporosis.

  1998cited by this paper
• Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

  1997cited by this paper
• Incidence and Direct Medical Costs of Hospitalizations due to Osteoporotic Fractures in Switzerland

  1997cited by this paper
• Clinical Grading of Spinal Osteoporosis: Quality of Life Components and Spinal Deformity in Women with Chronic Low Back Pain and Women with Vertebral Osteoporosis

  1997cited by this paper
• Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study.

  1997cited by this paper
• Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.

  1997cited by this paper
• Vitamin D Supplementation and Fracture Incidence in Elderly Persons

  1996cited by this paper
• A prospective study on socioeconomic aspects of fracture of the proximal femur

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

  1996cited by this paper
• Osteoporoseprävention : Paradigma Östrogensubstitution

  1996cited by this paper
• The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study

  1996cited by this paper
• Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study.

  1996cited by this paper
• Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

  1996cited by this paper
• Evidence based medicine: what it is and what it isn't

  1996cited by this paper
• Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study.

  1995cited by this paper
• Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

  1995cited by this paper
• Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

  1994cited by this paper
• [Incidence of femoral neck fractures in the German Federal Republic in comparison to other countries].

  1994cited by this paper
• Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

  1993cited by this paper
• Selection to postmenopausal therapy by women's characteristics.

  1993cited by this paper
• Effect of external hip protectors on hip fractures.

  1993cited by this paper
• Vitamin D3 and calcium to prevent hip fractures in elderly women.

  1992cited by this paper
• Treatment of postmenopausal osteoporosis with calcitriol or calcium.

  1992cited by this paper
• Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

  1990cited by this paper
• Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

  1990cited by this paper
• Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

  1990cited by this paper
• A study of complaints and their relation to vertebral destruction in patients with osteoporosis.

  1990cited by this paper
• Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.

  1990cited by this paper
• Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

  1989cited by this paper
• Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

  1989cited by this paper

• Einfluss einer auf Cyclosporin A basierenden immunsuppressiven Therapie auf den Knochenmineralstoffwechsel nach orthotoper Herztransplantation

  2014cites this paper
• Osseofix® System for Percutaneous Stabilization of Osteoporotic and Tumorous Vertebral Compression Fractures – Clinical and Radiological Results After 12 Months

  2013cites this paper
• Vergleich von Vertebroplastie und Kyphoplastie hinsichtlich Versagenslast, Versagensspannung und Lokalisation von Anschlussfrakturen - Eine biomechanische Ex-situ-Untersuchung an Wirbelsäulensegmenten des thorakolumbalen Übergangs mit verminderter Knochendichte

  2013cites this paper
• [Prevention and treatment of osteoporosis].

  2009cites this paper
• Behandlungsmöglichkeiten bei thorakalen und lumbalen osteoporotischen Problemfrakturen

  2008cites this paper
• Mikrocomputertomographische Analyse der trabekulären Architektur der thorakolumbalen Wirbelsäule

  2007cites this paper
• Therapieoptionen bei osteoporotischen Frakturen der Brustwirbelsäule

  2006influential citation
• Osteoporose: Ursache für Knochenbruch im Alter

  2005cites this paper
• Zeitgemäße medikamentöse, physiotherapeutische und orthetische Behandlung der Osteoporose

  2004cites this paper
• Osteoporose—Mode oder Krankheit?

  2004cites this paper
• Junger Patient mit multiplen pathologischen Frakturen

  2004cites this paper
• Evidenzbasierte Therapie der Osteoporose

  2003cites this paper
• Chronische Beschwerden des Bewegungsorgans - Bedeutung der Osteoporose bei rheumatischen Erkrankungen

  2003cites this paper
• Rehabilitation bei Osteoporose

  2003cites this paper
• Klinische Studien: „Stolpersteine“ bei Planung, Durchführung und Publikation — Eine kritische Betrachtung

  2002cites this paper